Sculco T P
Hospital for Special Surgery, New York, New York 10021, USA.
Am J Surg. 1995 Dec;170(6A Suppl):60S-63S. doi: 10.1016/s0002-9610(99)80061-0.
The orthopedic surgeon has several options available for blood conservation. Preoperative autologous donation (PAD) of blood is a cost-effective measure when the cost of managing transfusion-transmitted infectious disease is considered; overuse and underuse are expensive problems, however. Hemodilution, while used successfully in prostate surgery, is logistically impractical in joint replacement centers. Intraoperative blood salvage, although costly, is useful in orthopedic procedures when the anticipated blood loss is > 1,000 mL. Reinfusion of postoperative drainage that has been filtered and washed is being used in some orthopedic procedures. Studies are under way to determine whether this method of blood conservation alters transfusion requirements. Recombinant human erythropoietin (Epoetin alfa) has a role in elective procedures with significant blood loss, including complex revision joint replacement, bilateral joint arthroplasty, and spinal fusion. Preoperative Epoetin alfa administration enhances preoperative autologous blood collection and increases perioperative red blood cell mass.
骨科医生有多种血液保护方法可供选择。考虑到管理输血传播感染性疾病的成本,术前自体献血(PAD)是一种具有成本效益的措施;然而,过度使用和使用不足都是昂贵的问题。血液稀释虽然在前列腺手术中成功应用,但在关节置换中心在后勤方面不切实际。术中血液回收虽然成本高昂,但在预期失血量>1000 mL的骨科手术中很有用。一些骨科手术正在使用经过过滤和清洗的术后引流液回输。正在进行研究以确定这种血液保护方法是否会改变输血需求。重组人促红细胞生成素(阿法依泊汀)在有大量失血的择期手术中发挥作用,包括复杂的翻修关节置换、双侧关节置换和脊柱融合。术前给予阿法依泊汀可增强术前自体血采集并增加围手术期红细胞量。